Back

Metabolic health modifies SYNTAX II–Based revascularization risk beyond body mass index

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Obesity and coronary microvascular dysfunction Obesity ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Rami Abo Fanne

Hillel Yaffe Medical Center, Hadera (Israel)

4 More presentations in this session

Presentation thumbnail
Obesity modifies the prognostic value of serially measured laboratory values in a real-world HFpEF cohort
Ms E. Hatip Unlu (Rotterdam, NL)
Abstract
Presentation thumbnail
Gaps in obesity diagnosis and management among australians admitted with cardiovascular disease: a multi-centre audit
Doctor M. Lim (Gold Coast, AU)
Abstract
Presentation thumbnail
Central adiposity outperforms body mass index in predicting coronary artery disease: a prospective comparative study
Doctor G. Bettencourt Abreu (Funchal, PT)
Abstract
Presentation thumbnail
Roles of weight change from early to middle adulthood and BMI in relation to cardiometabolic disease risks: findings from the China Kadoorie Biobank
Miss Y. Chen (Oxford, GB)
Abstract

Access the full session

Session thumbnail
Obesity and coronary microvascular dysfunction

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of diabetes mellitus on myocardial revascularisation method in the light of the 2018 ESC/EACTS guidelines: Results from the PROUST Study
2 September 2019
thumbnail
Congress Presentation
Liver steatosis, metabolically healthy obesity and ten-year cardiovascular disease risk: results from a population based cohort study.
28 August 2021
thumbnail
Congress Presentation
Association between body mass index, left ventricular remodeling, and long term outcome in patients with bicuspid aortic valve
29 August 2025
thumbnail
Congress Presentation
Correlation between SYNTAX score and carotid intima-media thickness in patients with chronic coronary syndrome
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources